Sunesis Pharmaceuticals (SNSS) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts SNSS Hot Sheet
Price: $5.32 --0%
Financial Fact:
Total operating expenses: 10.6M
Today's EPS Names:
NLY, CP, RUSHA, More
Financial Fact:
Total operating expenses: 10.6M
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
Sunesis Pharmaceuticals (NASDAQ: SNSS) reported Q4 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $670 thousand versus the consensus estimate of $700 thousand.
For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
- SLM (SLM) Tops Q1 EPS by 20c; offers guidance
- Towne Bank (TOWN) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
